Horizons ETFs Rebalances Marijuana-Focused ETFs

Published: July 5, 2019

Horizons ETFs Rebalances Marijuana-Focused ETFs

Horizons ETFs Management (Canada) Inc. has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF (“HMMJ”:TSX), the Horizons US Marijuana Index ETF (“HMUS”:NEO) and the Horizons Emerging Marijuana Growers Index ETF (“HMJR”:NEO).

HMMJ is the world’s first ETF offering direct exposure to North American-listed securities that are involved with marijuana bioengineering and production. Once again, the ETF has added additional companies to its portfolio as more firms have become eligible for inclusion in its underlying index – the North American Marijuana Index.

The HMMJ portfolio recently expanded to include the following 10 constituents:

Company Name

Ticker

Exchange

Sproutly Canada Inc.

SPR

Canadian Securities Exchange

Valens Groworks Corp.

VGW

Canadian Securities Exchange

Abacus Health Products Inc.

ABCS

Canadian Securities Exchange

Corbus Pharmaceuticals Holdings

CRBP

NASDAQ

Cardiol Therapeutics Inc.-A

CRDL

Toronto Stock Exchange

Enwave Corp.

ENW

TSX Venture Exchange

Intec Pharma Ltd.

NTEC

NASDAQ

Pyxus International Inc.

PYX

NYSE American

cbdMD Inc.

YCBD

NYSE American

Youngevity International Inc.

YGYI

NASDAQ

HMMJ is an index (or passively managed) ETF, which seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. This index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the Marijuana industry. The North American Marijuana Index selects from a current universe of companies that have operations that may include one or more of biopharmaceuticals, medical manufacturing, distribution, bio-products and other ancillary businesses related to the Marijuana industry.

“The last quarter was a difficult one for Marijuana-sector investors. After more than a 50% run-up in the value of HMMJ, performance in the sector tailed off. Nevertheless, HMMJ is still up more than 30% year to date, so it remains one of the strongest-performing equity sectors in 2019,” said Steve Hawkins, President and CEO of Horizons ETFs. “During this rebalance, we saw a lot of U.S.-listed stocks enter the North American Marijuana Index, and by extension the ETF. Many of these producers, such as cbdMD and Youngevity International, are involved in the legal CBD and Hemp markets in the U.S. We expect that as the industry grows, so too will the number of U.S. legal CBD-focused firms that will qualify for index inclusion.”

Rebalancing of the North American Marijuana Index, and consequently HMMJ, occurs each calendar quarter. At that point, all stocks eligible for inclusion are generally re-weighted by their respective market capitalization. The holdings of HMMJ and its current portfolio weights are regularly updated and available at https://www.HorizonsETFs.com/HMMJ.

Recent News

View All News Items

Latest Article

Legalization 2.0: IP and Regulatory Considerations for Edibles, Extracts and Topicals

Legalization 2.0: IP and Regulatory Considerations for Edibles, Extracts and Topicals

The legalization of cannabis edibles, extracts and topicals will expand the cannabis market and create new opportunities for producers, innovators and investors. According to a recent report from Deloitte, the Canadian market for these new cannabis products is expected to be worth $2.7 billion annually, with edibles accounting for more than half ($1.6 billion).

 

Read Article